Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Robinhood Expands Sports Event Contracts With Player Performance Wagers 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Philip Morris International Inc. (NYSE: PM) is reportedly exploring the sale of its cigar business for over $1 billion, according to Bloomberg. The move aligns with the tobacco giant’s strategy to transition toward smoke-free products.
Philip Morris acquired the cigar unit through its 2022 purchase of Swedish Match, a deal aimed at expanding its smoke-free portfolio. Since then, the company has successfully introduced Swedish Match’s popular ZYN nicotine pouches in the U.S., fueling strong demand.
Despite this shift, traditional cigarettes, particularly the iconic Marlboro brand, remain a key revenue driver. While Philip Morris is pushing alternatives in the U.S., international sales still rely heavily on cigarette demand, especially in emerging markets.
The company recently reported better-than-expected fourth-quarter earnings and provided an optimistic outlook for 2025. Its IQOS smoke-free device is also gaining traction in the U.S., following FDA approval in early 2024.
With growing demand for smoke-free alternatives, Philip Morris’ potential cigar business sale marks another step in its transformation strategy.
